Identification and infection control response to Candida auris at an academic level I trauma center

Michael A Goulart; Rayan El Itani; Stefanie R Buchanan; David S Brown; Amanda K Hays; Walker B King; Dana L Luciani; Chad D Neilsen; Jorge L Verdecia

doi:10.1016/j.ajic.2023.11.017

Identification and infection control response to Candida auris at an academic level I trauma center

Am J Infect Control. 2024 Mar;52(3):371-373. doi: 10.1016/j.ajic.2023.11.017. Epub 2023 Nov 28.

Authors

Michael A Goulart¹, Rayan El Itani², Stefanie R Buchanan², David S Brown², Amanda K Hays², Walker B King², Dana L Luciani², Chad D Neilsen², Jorge L Verdecia³

Affiliations

¹ Department of Infection Prevention and Control, University of Florida Health Jacksonville, Jacksonville, FL. Electronic address: michael.goulart@jax.ufl.edu.
² Department of Infection Prevention and Control, University of Florida Health Jacksonville, Jacksonville, FL.
³ Department of Medicine, Division of Infectious Disease, University of Florida Health Jacksonville, Jacksonville, FL.

PMID: 38036181
DOI: 10.1016/j.ajic.2023.11.017

Abstract

Candida auris, an emerging fungal pathogen with significant morbidity and mortality, can be difficult for health care facilities to identify, isolate, and control. We present our identification and infection control response to Candida auris at a 695-bed academic level I trauma center in Florida.

Keywords: Disinfection; Emerging diseases; Infection prevention and control; Surveillance.

MeSH terms

Antifungal Agents / pharmacology
Antifungal Agents / therapeutic use
Candida auris
Candida*
Candidiasis* / drug therapy
Candidiasis* / epidemiology
Candidiasis* / prevention & control
Humans
Infection Control
Trauma Centers

Substances

Antifungal Agents